Did FDA fully analyse Pfizer trial data in 22 days? Impossible, says expert

FDA claims it fully analysed the individual participant data (IPD) underpinning the emergency authorisation of Pfizer's covid-19 vaccine in only 22 days. Experts say the agency must've cut corners.

In 2020, governments around the world imposed brutal lockdowns across the population, promising a safe and effective covid-19 vaccine was just around the corner.

The Trump administration made no secret of the fact that it wanted the Food and Drug Administration (FDA) to hurry the process along.